潰瘍性結腸炎的研究

從行為 1 審判的最近證據表明該單抗可能誘導和維持疾病緩解期更大的作用。

中產生的有毒氣體硫化氫濃度高的潰瘍性結腸炎，有些病人出現過結腸硫酸鹽還原菌的增加的量。硫化氫在發病中的作用尚不清楚。有人建議防護效益吸煙，一些病人報告是由於氫氰化物香煙煙霧與硫化氫生產無毒的異硫氰酸酯的反應。另一種不相關的研究紅肉中所載的建議的硫和酒精可能會導致在緩解患者復發的風險增加。

有很多研究，目前正在做進一步闡明遺傳標記在潰瘍性結腸炎。有人提議與人類白細胞抗原 B-27，與其他自身免疫性疾病相關的聯繫。

低劑量納曲酮是根據克羅恩病和潰瘍性結腸炎的治療研究。

進一步閱讀

這篇文章是創作共用署名-相同方式共用授權許可。它使用材料從維琪百科上"潰瘍性結腸炎"適應所有材料用從維琪百科的文章是創新的知識共用署名-相同方式共用許可證的條款下提供。維琪百科 ® 本身是維琪媒體基金公司的註冊的商標

Recent Ulcerative Colitis News

Bone age necessary to correctly interpret growth status in pediatric Crohn's diseaseMeasuring bone age should be a standard practice of care for pediatric patients with Crohn's disease, in order to properly interpret growth status and improve treatment, according to a new study from ...

Measuring bone age should be part of routine care for pediatric patients with Crohn's diseaseMeasuring bone age should be a standard practice of care for pediatric patients with Crohn's disease, in order to properly interpret growth status and improve treatment, according to a new study from ...

New research reveals effective treatments for gastrointestinal conditionsNew research being presented at Digestive Disease Week- (DDW) reveals effective treatments for a number of gastrointestinal conditions, which are often chronic and costly.

Data from Janssen’s SIMPONI Phase 3 study on ulcerative colitisNew study findings presented today show that subcutaneous induction regimens of the anti-tumor necrosis factor (TNF)-alpha therapy SIMPONI (golimumab) induced clinical response in a majority of patien...

Santarus to present UCERIS Phase III trial data on ulcerative colitis at DDW meetingSantarus, Inc. today announced that safety and efficacy data from a Phase III, double-blind, multicenter, placebo-controlled 12 month extended use study with the investigational drug UCERIS (budesonid...